CD56 and terminal deoxynucleotidyl transferase positive cutaneous lymphoblastic lymphoma.
Amo
Y
Y
Yonemoto
K
K
Ohkawa
T
T
Sasaki
M
M
Isobe
Y
Y
Sugimoto
K
K
Katsuoka
K
K
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019002:CD56 Antigen / Q000276:immunology*; D004253:DNA Nucleotidylexotransferase / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology*; D016896:Treatment Outcome
D019002:CD56 Antigen; D004253:DNA Nucleotidylexotransferase